-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
DSHS00884
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/675104-49-1.gif)
| Category | Filovirus |
| CAS | 675104-49-1 |
| Description | DSHS00884 is a potent human papillomavirus E6 inhibitor with an IC50 of 10 μM. |
Product Information
| Synonyms | SSYA10-001|675104-49-1|DSHS00884|MLS001181552|3-[(2-nitrophenyl)sulfanylmethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione|SMR000567368|3-((2-Nitrophenyl)sulfanylmethyl)-4-prop-2-enyl-1H-1,2,4-triazole-5-thione|DC9CUH9LJY|UNII-DC9CUH9LJY|Ssya 10-001|CHEMBL1595621|SCHEMBL15398584|BDBM61876|cid_2807230|HMS2884A17|SSYA-10-001|CCG-45281|ZINC15923400|HY-113794|CS-0065749|SR-01000635060-1|4-allyl-3-[[(2-nitrophenyl)thio]methyl]-1H-1,2,4-triazole-5-thione|3-((2-Nitrophenyl)sulfanylmethyl)-4-(prop-2-enyl)-1H-1,2,4-triazole-5-thione|3-[(2-nitrophenyl)sulphanylmethyl]-4prop-2-enyl-1h-1,2,4-triazole-5-thione|3-[[(2-nitrophenyl)thio]methyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione|3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-(((2-nitrophenyl)thio)methyl)-4-(2-propenyl)-|2,4-Dihydro-5-(((2-nitrophenyl)thio)methyl)-4-(2-propen-1-yl)-3H-1,2,4-triazole-3-thione|3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-(((2-nitrophenyl)thio)methyl)-4-(2-propen-1-yl)- |
| Molecular Weight | 308.38 |
| Molecular Formula | C12H12N4O2S2 |
| Canonical SMILES | C=CCN1C(=NNC1=S)CSC2=CC=CC=C2[N+](=O)[O-] |
| Purity | 98.24% |
| Solubility | In Vitro: DMSO : 250 mg/mL(810.69 mM;Need ultrasonic) In Vivo: 1.Add each solvent one by one:10% DMSO >> 40%PEG300 >> 5%Tween-80 >> 45% saline Solubility: ≥ 2.08 mg/mL (6.74 mM); Clear solution 2.Add each solvent one by one:10% DMSO >> 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.08 mg/mL (6.74 mM); Clear solution |
| Appearance | Off-white to light yellow (Solid) |
| Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
| Complexity | 436 |
| Exact Mass | 308.04016799 |
| Target | IC50: 10 μM (human papillomavirus E6) |
| XLogP3-AA | 2.7 |
